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1. Introduction 
The glycoprotein crs-macroglobulin ((YAM), M, 
725 000, is unique among plasma proteins in being 
able to form complexes with proteinases from all 4 
classes (EC 3.4 2 1-24) [ l-31. The function of olM is 
not well understood. However, the rapid clearance of 
osM-proteinase complexes from the blood by the retic- 
uloendothelial system [4] and the uptake of a,M or 
r+M-proteinase complexes via receptors by several 
types of cell in culture [5-81 indicates that cuzM plays 
a role in the transport of proteinases and possibly 
other proteins into cells. 
The binding of proteinases to crzM is initiated by 
cleavage of one or more of the Mr 180 000 subunits 
of crzM in the ‘bait region’ 193, producing two Mr 
85 000 fragments [ 1 ,I O-121. There appears to be a 
close-fitting binding site in this area since even auhy- 
drotrypsin binds to crIZM [ 131. The exact position of 
cleavage in the ‘bait region’ reflects the known sub- 
strate specificity of the particular proteinase being 
complexed (trypsin, plasmin, thrombin’, elastase). Fol- 
lowing cleavage, the initial complex, involving the 
proteinase active site and the cvzM ‘bait region’, is rear- 
ranged to form a final complex, involving a second 
site in the proteinase and probably also in cr2 M (L. S.-J., 
T. E. P., S. M., 11. Jdrnvall, in preparation). In the 
final complex cvzM may well be covalently linked to 
the proteinase [9 ,141. The subunits of ol,M can be 
cleaved specifically by heating, into two fragments of 
Mr 120 000 and Mr 60 000 [15-l 71. This polypeptide 
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chain cleavage occurs at the cr-amino group of a par- 
ticular Glx-residue [161, whose ycarboxyl group is 
also the site of covalent incorporation of methylamine 
[ 181 during ‘inactivation’ of the proteinase binding 
capacity of ar2M [19,201. The latter two processes are 
apparently mutually exclusive [16,18]. 
The complement components C3,4 and 5 are also 
inactivated by aliphatic amines [19,2 l]. The recent 
demonstration that CHsNH2 can react covalently with 
a Glx-residue in C3 [22] indicates that cr2M, C3, C4 
and C5 are structurally and functionally related. 
This report concerns apreviously unrecorded 
appearance of thiol groups in ar2M (max. 4 mol/mol 
azM) accompanying complex formation with protein- 
ases. This SH- appearance is also observed when cr2M 
is ~~activated’ by CHBNH2 or by denaturation. The 
implications of this for the mechanism of cu2M are dis- 
cussed and we conclude that the CHsNH2-reactive 
Glx-residue [181 is in fact bound as a y-glutamyl thiol 
ester to the SH of a cysteinyl residue. 
2. Materials and methods 
Human cvzM was prepared by Zn’*-chelate affinity 
chromatography [23] using a slight modification of a 
method in [24] as summarized: Following removal of 
plasminogen [25] and precipitation of plasma with 
polyethylene glycol (av.M, 4000,4-12%, w/v) the 
precipitate was redissolved in 20 mM phosphate buffer 
(PH 6.4) and dialyzed against running tap-water 
(11°C). After removal of euglobulins by centrifuga- 
tion 02M was adsorbed to Zn2’-Sepharose 4B. Fol- 
lowing extensive washing with phosphate (pH 6.4)/ 
0.5 M NaCI cw2M was eluted with 0.1 M NazEDTA 
(PH 7 -0). After gel filtration on Sephacryl S-300 in 
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0.05 M Na-phosphate, 0.1 M NaCl (pH 8.0) the result- 
ing lvzM preparations were found to protect 1.7-2.0 
mol trypsin/mol CQM from inhibition by STI, when 
assayed by active site titration us~ng~-NPGB 126,271. 
The solutions of cxzM were concentrated to 9-12 mg/ 
ml by ultrafiltration and stored at -2O’C. TPCK 
treated bovine trypsin (active site titre 52%) and ST1 
were obtained from Worth~gton (Freehold NJ) and 
porcine pancreatic elastase (assumed to contain -50% 
active nzyme) was a gift from D. Shotton (Cambridge). 
DTNB was obtained from Fluka (Buchs). I.I-NPGB was 
from Merck (Darmstadt). Bovine trypsinogen and 
CHsNH2 . HCl were from Sigma (St Louis MO). 
14CHsNHz - HCl was from New England Nuclear 
(Boston MA) (48 Ci~mol). The buffer used for all incu- 
bations was made from Na2HP04 (0.1 M), Na*EDTA 
(2 mM) adjusted to pH 8.0 with HCl. The stock solu- 
tion of lvzM used in all experiments was 13.3 PM. Tryp- 
sin was dissolved in 1 mM HCI (active site 107.8 yM) 
and kept at room temberature. Elastase was dissolved 
in the phosphate buffer (active site -105 @l) and 
kept at 0°C before use. Stock solutions of 0.1 M 
CHBNHz - HCl and 6 M ~anid~ium chloride were 
prepared in the phosphate buffer and the pH read- 
justed to 8.0 with NaOH. All absorbance measure- 
ments were performed in a Beckman DB-24 spectro- 
photometer at room temperature (22-23OC). The 
concentration of a2M was determined using E$$ = 9.1 
[28] and M, = 72.5 000 [29]. [Thiol] were determined 
using e410 = 13 600 M-’ . cm-’ at pH 8.0 [30]. Avalue 
of eq05 = 16 240 M-’ . cm-’ for p-nitrophenol was 
used [31]. 14C was countedin a Beckman LS-330 scin- 
tillation counter using 0.24% 2,5-diphenyloxazole 
(Sigma) in xylene .
3. Results and discussion 
When cuzM was incubated with 1 mM DTNB under 
non-denaturing conditions an increase in A 410 that 
remained constant for 220 h at room temperature 
was observed, indicating 0.2 mol thiol/mol native CY~M. 
Adding sufficient rypsin to saturate arzM e2 mol 
trypsin/mol azM) [l,lO-121 led to a rapid (5-10 s) 
increase in absorbance to a new level which remained 
constant for >2 h, A similar increase in absorbance 
also occurred if ~QM had been preincubated with tryp- 
sin for 1 or 10 min and then added to DTNB solution. 
Inhibition of excess trypsin with ST1 did not affect 
these results. After ar?M-trypsin compIex had first 
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been incubated with 15 mM ICH,CONH, for 10 min 
adding DTNB did not lead to an increased in A 410. 
This‘ constitutes independent evidence that the groups 
made available to titration with DTNB as a result of 
incubating cuZM with trypsin are indeed thiol groups. 
If trypsinogen (a mol/mol Q~M) was used instead of 
trypsin , no SH-groups appeared. 
Fig.1 shows the results of incubating afixed [%Ml 
with increasing [trypsin] or [elastase], and of active- 
site titration of the bound trypsin. The maximal level 
of thiol appearing was 3.74 mollmol azM indicating 
that each of its four subunits may contribute one SH- 
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Fig.1. Appearance of thiol-groups in or,M at varying concen- 
trations of trypsin or elastase, compared with complex forma- 
tion with trypsin. Thiol generation: To cuvettes containing 
700-620 ~1 phosphate buffer and 200 ~1 or,M stock solution 
was added O-80 ~1 trypsin or elastase solution. The reference 
cuvette contained 900-820 i.cl phosphate buffer and O-80 ~1 
proteinase. After mixing by inversion for 15 s the cuvettes 
were incubated at room temperature for 105 s and the A,,, 
adjusted to zero. Then each cuvette received 100 ~1 10 mM 
DTNB in phosphate buffer and the contents were mixed by 
inversion for 15 s. AA,,, was determined. Release of thioi 
with trypsin (w), release of thiol with ehstase (0). Final con- 
centration of ol,M in the cuvcttes was 2.66 /.IM. Active site 
titrationof bound trypsin: To cuvettes containing 690-610 ~1 
phosphate buffer and 200 ~1 a,M solution was added O-80 ~1 
trypsin solution. The reference cuvette contained 890-810 ~1 
phosphate buffer and O-80 E.II trypsin solution. After mixing 
by inversion for 15 s the cuvettes were incubated at room 
temperature for 45 s before 100 ~1227 PM ST1 in phosphate 
buffer was added and the contents mixed. After adjusting the 
A,,, to zero 10 ~1 10 mM p-NPGB in dimethyisulfoxide was 
added and the contents mixed by inversion. The A,,, was 
measured at 10 s intervals and extrapolated to the time of 
mixing. Release ofp-nitrophenol (0). Final concentration of 
r,M in the cuvettes was 2.66 PM. 
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group. The trypsin-binding capacity was determined 
as 1.88 mol trypsin/mol cllzM confirming earlier esti- 
mates [ 1 JO-121 of 2 mol/mol. On the rising part of 
the two curves (<2 PM enzyme) 3.7 mol SH appear/ 
mol proteinase added, indicating that even binding of 
only 1 proteinase molecule suffices to cause the 
appearance of 4 SH-groups. Under these conditions 
only two ~~M-subunits were cleaved, as shown in 
[IJO-121. 
Addition of more cu,M to already formed CQM- 
trypsin complex (trypsin:cusM = 1: 1 mol/mol) did 
not cause the appearance of additional thiol groups 
(not shown). Therefore, we conclude that trypsin in 
its final complex with oZM is effectively prevented 
from reacting with other uncleaved cr*M-molecules. 
However, the data in fig.2 (results of incubating a 
fixed [trypsin] with different [cu,M]) indicate that in 
a large excess of oZM (3-6.4 PM) an additional gener- 
ation of up to 3.2 FM thiol was observed above the 
anticipated level of 8.8 PM. This may be due to a delay 
between the initial tryptic cleavage of CQM and the 
formation of the final cu,M-trypsin complex. Not 
only incubation with proteinases but also treatment 
with methylamine leads to the appearance of thiol 
groups as shown in tig.3. The maximal level of thiol 
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Fig.2. Appearance of thiol groups in (Y*M at varying [cy,M]. 
Trypsin was 4.31 PM. The cuvettes contained 820-360 ~1 
buffer solution, 40 ~1 trypsin and 40-500 rl or,M solution. 
The reference cuvette contained 860 ~1 phosphate and 40 ~1 
trypsin solution. After incubation for 120 sand adjustment 
to zero the cuvettes each received 100 ~1 10 mM DTNB and 
AA a,0 was measured. 
groups appearing is equal to that produced by protein- 
ases. Fig.3 also shows that the relatively slow appear- 
ance of thiol on addition of methylamine is accom- 
panied by a corresponding decrease in the trypsin- 
binding capacity of CQM. The sum of the thiol groups 
that have already appeared as a result of methylamine 
treatment and additional thiol groups that appear 
immediately when trypsin is added, remains constant. 
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Fig.3. Appearance of thiol in cu,M on incubation with meth- 
ylamine (50 mM). a,M solution (4.0 ml) was mixed with 
4.0 ml 0.1 M CH,NH, in phosphate buffer (mixture A). 
Assay of thiols: 400 ~1 aliquots were removed at intervals and 
added to a cuvette containing 500 ~1 phosphate buffer. The 
A d,O was adjusted to zero against a reference cuvette contain- 
ing 400 ~150 mM CH,NH, in phosphate buffer plus 500 ~1 
phosphate buffer. After addition to each cuvette of 100 ~1 
10 mM DTNB aA 4,0 was measured. Then each cuvette’ 
received 100 ~1 trypsin solution and after incubation for 120 s 
aA,,, was again measured. Appearance of thiols with methyl- 
amine only (0); after further addition of excess trypsin (=). 
Active site titration of bound trypsln: 400 ~1 samples (mix- 
ture A) were added to cuvettes containing 390 ~1 phosphate 
buffer. The reference cuvette contained 390 ~1 phosphate 
buffer plus 400 ~150 mM CH,NH, in phosphate buffer. After 
addition of 100 ~1 trypsln, 100 ~1 ST1 and 10 ~1 p-NPGB to 
each cuvette the A 4,,5 was measured as in fig.1. Release of 
p-nitrophenol (0). cu,M was 2.66 PM in the cuvette. Determi- 
nation of incorporation of CH,NH,: 250 ~1 (YAM solution was 
mixedwith 250 ~10.1 M CH,NH, * HCl in phosphate (pH 8.0) 
containing 100 PC1 14CH,NH, . HCl. Aliquots (50 ~1) of this 
mixture were removed and mixed with 50 ~11 M NH,HCO,. 
Portions (80 ~1) were spotted on 2 cm diam. pieces of 
Whatman 3MM paper and immediately dropped into cold 
10% trichloroacetic acid and stirred. After extensive washing 
with 5% trichloroacetic and ethanol/acetone (1:l) the radio- 
activity was determined (0). 
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Furthermore, the incorporation of [ 14C]methylamine 
into CQM closely parallels the appearance of thiol 
groups and the decrease in the binding capacity of 
a,M for trypsin, strongly indicating that the Glx-resi- 
due identified earlier as acceptor of methylamine [ 181 
is part of a site in a,M which mediates the covalent 
attachment of proteinase to CQM. The maximal amount 
of [ “C]methylamine incorporated was found to be 
4.0-4.2 mol/mol azM confirming the results in [ 181. 
Fig.4 shows that the rapid appearance of thiol 
groups in cuzM can also be caused by denaturants such 
as guanidinium chloride or SDS, showing that the 
reactions which lead to the somewhat slower cleavage 
of the OL?M subunits into Mr 120 000 and Mr 60 000 
fragments [ 1 S-l 71 depend on prior appearance of the 
thiol groups. Based on these observations we conclude 
that the methylamine-accepting Glx-residue [ 181 of 
the sequence -Pro-Tyr-Gly-Cys-Gly-Glu-Glx- 
Asn-Met-Val-Leu-Phe-Ala-Pro-Asn-Ile-Tyr- 
Val-Leu-Asp-Tyr-Leu- occurs in all 4 chains of 
cw,M as a reactive y-glutamyl-thiolester. Preliminary 
-!, _ , ‘ , , , 
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Fig.4. Appearance of thiol groups on denaturation of o,M. 
cc,M solution (2.5 ml) was mixed with 1.25 ml 6 M guanidi- 
nium chloride buffer (pH 8.0) and kept at 50°C. Samples 
(300 ~1) were removed at intervals and added to 600 ~1 phos- 
phate buffer at room temperature. The reference cuvette con- 
tained 600 ~1 phosphate plus 300 ~12 M guanidinium chloride 
in phosphate buffer (pH 8 .O). After adjusting the A 4,,, to zero, 
each cuvette received 100 ~1 10 mM DTNB and aA,,, was 
measured (m). In another experiment 1 .O mlo,M solution was 
mixed with 200 ~110% SDS in water and kept at 50°C. Sam- 
ples (200 ~1) were added to 700 ~1 phosphate buffer and the 
A 4,0 adjusted to zero against a reference containing 700 ~1 
phosphate plus 200 ~1 1.67% SDS. After addition of 100 ~1 
DTNB the AA 4,0 was measured (0). 
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Fig.5. Schematic representation of the reaction paths of the 
proposed thiolester in the subunits of oZM: (1) activation by 
proteinase; (2) reaction with methylamine; (3) effect of dena- 
turation resulting in the formation of an internal pyroglutamyl 
residue in o,M followed by secondary reactions. Cleavage (A) 
leads to formation of 120 000 A$ and 60 000 Mr fragments 
[15,16]. 
results show that the SH is contributed by a cysteine 
residue in the CQM sequence (fig.5). As a result of 
cleavage by proteinases in the ‘bait region’ of cw,M this 
thiol-ester immediately becomes accessible to rapid 
reaction with a suitably oriented nucleophile, e.g., on 
the surface of the ‘attacking’ proteinase leading to an 
‘acyl transfer’ reaction of the cwzM via its Glx-residue 
to the proteinase. Thus, the reactive site of crzM resem- 
bles the thioester proposed as an intermediate in the 
transghrtaminase catalyzed formation of isopeptide 
bonds [32]. The thiolester in oZM is so labile that 
treatment with denaturants leads to its cleavage even 
at room temperature. Incubation of azM in buffers at 
pH <4.5 or pH >9.5 also makes the thiol groups 
appear rapidly. 
The fact that in conditions of azM excess (sloping 
part of fig.1) the stoichiometry is 4: 1 between thiol 
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released and trypsin added, for two chains cleaved, 
suggests that only half of the total thiol release is 
strictly correlated to the extent of proteolytic cleav- 
age. This could mean that the structural change trig- 
gered by this proteolytic cleavage is ‘transmitted’ to 
the two uncleaved subunits in the CQM tetramer, thus 
causing their two thiolesters to be cleaved. 
Note added 
After this manuscript was typed we became aware 
of an abstract (Tack, B. F., Harrison, R. A., Janatova, 
J. and Prahl, J. W., 4th Int. Cong. Immunol. Paris, 
July 21-26, 1980,no. 15.1.19)indicatingthe pres- 
ence of an internal thiol-ester in complement factor C3. 
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